Karthik Venkatakrishnan

Statistics

Publications

118

Citations

7.4K

H-Index

Active since

1975

Affiliations

Millennium Engineering and Integration (United States)(Current)

Takeda (United States)

Takeda (Japan)

Tufts University

Ono Pharmaceutical (United States)

Karthik Venkatakrishnan is an author at Millennium Engineering and Integration (United States) specializing in pharmacology, medicine, and pharmacokinetics.

ORCID

Publications per year

1975–2024

118

Publications

118

Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug Interactions

R. Scott Obach, Robert L. Walsky, Karthik Venkatakrishnan · Drug Metabolism and Disposition · 2006 · 456 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL

Angela C. Doran, R. Scott Obach, Bill J. Smith et al. · Drug Metabolism and Disposition · 2004 · 440 citations

Medicine, Pharmacokinetics, Pharmacology +16

The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions

R. Scott Obach, Robert L. Walsky, Karthik Venkatakrishnan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 437 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

CYP2B6 Mediates the In Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants

L M Hesse, Karthik Venkatakrishnan, Michael H. Court et al. · Drug Metabolism and Disposition · 2000 · 399 citations

Medicine, Biochemistry, Pharmacology +17

Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine

Kirk Bertelsen, Karthik Venkatakrishnan, Lisa L. von Moltke et al. · Drug Metabolism and Disposition · 2003 · 276 citations

Medicine, Pharmacokinetics, Pharmacology +17

1–5 of 118